Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SepThrom: Exploring the Relationship Between Sepsis, VTE and DIC in RWD.

NCT06765681 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06765681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06765681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SepThrom: Exploring the Relationship Between Sepsis, VTE and DIC in RWD.
Lead sponsor
Bayer
Phase
Observational
Overall status
Active, not recruiting
Start date
January 6, 2025
Completion date
August 31, 2026
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disseminated intravascular coagulation, sepsis, venous thromboembolism